Novacyt obtient un financement via des obligations convertibles
23/04/2019
RNS
Novacyt expands development partnership with Immunexpress
08/04/2019
NOVACYT ÉTEND SON PARTENARIAT DE DÉVELOPPEMENT AVEC IMMUNEXPRESS
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
06/04/2019
06/03/2019
International Animal Rescue to use Primerdesign genesig q16 and selected assays
INFORMATION SUR LE FINANCEMENT
26/02/2019
NEW! Molecular diagnostic tests to help transplantation and immunosuppressed patients
12/02/2019
05/02/2019
NOVACYT CHIFFRES D’AFFAIRE ANNUEL 2018
22/01/2019
NEW! genesig® qPCR Detection Kits for African Swine Fever Virus
17/01/2019
07/01/2019
Novacyt launches two new CE-IVD Marked molecular diagnostic kits
21/12/2018
Completion of substantial q16 molecular diagnostics order
06/12/2018
06/11/2018
03/10/2018
NOVACYT PARTNERS WITH APPLIED MICROARRAYS IN ASSAY DESIGN
13/09/2018
New research shows a fifth of samples contain unspecified animals’ DNA
05/09/2018
Novacyt Announces Acquisition of Infectious Disease Business from Omega Diagnostics
28/06/2018
Pour toute assistance concernant les relations investisseurs chez Novacyt Group, veuillez cliquer sur le bouton ci-dessous pour contacter notre équipe.
